The salt has the molecular formula C 10 H 11 IN 2 , a molecular weight of approximately 286.11 g/mol, and CAS number 42464-96-0
Youll also learn how weight loss may unfold differently for women on GLP-1s, what to watch for in terms of hormonal shifts or fertility, and when to reach out to your provider for extra support
How Retatrutide Compares to Other Weight Loss Medications The Triple Agonist Advantage Retatrutide's unprecedented efficacy stems from its unique mechanism as a triple hormone receptor agonist , activating three complementary pathways: GLP-1 (Glucagon-Like Peptide-1): Reduces appetite, slows gastric emptying, improves insulin secretion GIP (Glucose-Dependent Insulinotropic Polypeptide): Enhances GLP-1 effects, improves insulin sensitivity, may affect fat metabolism Glucagon: Increases energy expenditure, promotes fat burning, may improve metabolic rate Head-to-Head Comparison Retatrutide's 6.2 percentage point improvement over tirzepatide and 13.7 percentage point improvement over semaglutide represents a substantial therapeutic advance
These outcomes not only improve patient health and quality of life but also increase physician confidence in prescribing GLP-1 therapies